Metabolomics

Dataset Information

0

CD22 Blockade Alleviates Anesthesia Surgery-Mediated Cognitive Impairment in Aged Mice


ABSTRACT:

Postoperative cognitive dysfunction (POCD) is a common complication characterized by cognitive decline following surgery, with neuroinflammation serving as a critical pathogenic mechanism. Emerging evidence indicates that CD22, an inhibitory receptor primarily expressed on B cells and microglia, plays a key immunomodulatory role in the central nervous system. This study aims to investigate the role of CD22 in mitigating neuroinflammation and ameliorating POCD. Using a murine model of sterile laparotomy, we observed that surgery-induced cognitive impairment was associated with exacerbated hippocampal inflammation and enhanced microglial activation. In contrast, upregulation or agonism of CD22 signaling significantly reduced the release of pro-inflammatory cytokines, including TNF-α and IL-1β, and suppressed microglial overactivation. Notably, CD22-modulated mice exhibited markedly improved performance in behavioral tests assessing learning and memory compared to control groups. Our findings demonstrate that CD22 activation confers protection against POCD by inhibiting surgery-induced neuroinflammation through the S100a9 signaling pathway. Therefore, targeting the CD22 pathway may represent a promising therapeutic strategy for the prevention or treatment of postoperative cognitive dysfunction.

INSTRUMENT(S): Liquid Chromatography MS - alternating - reverse phase

PROVIDER: MTBLS13028 | MetaboLights | 2025-09-24

REPOSITORIES: MetaboLights

Dataset's files

Source:

Similar Datasets

2024-11-14 | GSE267933 | GEO
2022-12-09 | GSE215410 | GEO
2024-03-13 | GSE199318 | GEO
2024-05-20 | GSE247651 | GEO
2026-01-04 | GSE315250 | GEO
2025-04-01 | PXD062444 |
2025-02-18 | GSE286221 | GEO
2025-02-18 | GSE287125 | GEO
2025-09-08 | PXD064537 | Pride
2023-11-30 | GSE247222 | GEO